Department of Internal Medicine, Division Gastroenterology, Texas Tech University Health Science Center, 3601 4th street, Lubbock, TX 79430, USA.
Dig Dis Sci. 2011 Sep;56(9):2728-34. doi: 10.1007/s10620-011-1647-5. Epub 2011 Mar 11.
Antibiotic prophylaxis can reduce the incidence of the first episode and recurrent episodes of spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients. However, recent data suggest that SBP prophylaxis may be underused. It is unclear how many cases of cirrhosis that develop SBP might actually be prevented with antibiotic prophylaxis.
To determine the number of "preventable" cases of SBP and the adherence to standard guidelines for the use of antibiotic prophylaxis.
A retrospective analysis of our patients diagnosed with SBP was performed. AASLD Guidelines (2004) for SBP prophylaxis include prior SBP, gastrointestinal (GI) hemorrhage, ascitic fluid (AF), protein ≤ 1 g/dl, or serum bilirubin ≥ 2.5 mg/dl. "Preventable (P) SBP" was defined as SBP occurring where prophylaxis was indicated but was not administered. "Non-preventable (NP) SBP" was defined as SBP that occurred despite proper adherence to the guidelines. "Inevitable (I) SBP" were those cases of SBP occurring in the absence of a documented indication for prophylaxis.
A total of 259 patients with cirrhosis underwent paracentesis; 29 had confirmed SBP. Eighteen of the 29 patients (62%) had "P-SBP", one (3%) had "NP-SBP", and ten (34%) had "I-SBP". In the P-SBP cases, the overlooked indications for prophylaxis were GI hemorrhage (n, %) (8, 44%), serum bilirubin ≥ 2.5 mg/dl (6, 33%), prior SBP (2, 11%) and AF protein ≤ 1 g/dl (2, 11%). Of the P-SBP, 78% were community-acquired; 22% were nosocomial. In-hospital mortality in the P-SBP was 16% (n = 3). Only one-third of patients who survived SBP received long-term outpatient prophylaxis after discharge.
Many cases of SBP could be prevented by adhering to the AASLD guidelines. GI hemorrhage is the most frequently overlooked indication for SBP prophylaxis. Studies identifying the reasons for non-adherence to guidelines and developing interventions to increase utilization are warranted.
抗生素预防可降低高危肝硬化患者自发性细菌性腹膜炎(SBP)首次发作和复发性发作的发生率。然而,最近的数据表明,SBP 的预防可能使用不足。尚不清楚抗生素预防可预防多少例肝硬化并发 SBP。
确定“可预防”的 SBP 病例数和遵循抗生素预防使用标准指南的情况。
对诊断为 SBP 的患者进行回顾性分析。AASLD 指南(2004 年)将先前的 SBP、胃肠道(GI)出血、腹水(AF)、蛋白≤1g/dl 或血清胆红素≥2.5mg/dl 列为 SBP 预防的指征。“可预防(P)SBP”定义为有预防指征但未给予预防的 SBP。“不可预防(NP)SBP”定义为尽管遵循了指南,但仍发生 SBP。“不可避免(I)SBP”是指在没有记录的预防指征的情况下发生的 SBP。
共有 259 例肝硬化患者行腹腔穿刺术;29 例确诊为 SBP。29 例患者中 18 例(62%)患有“P-SBP”,1 例(3%)患有“NP-SBP”,10 例(34%)患有“I-SBP”。在 P-SBP 病例中,被忽视的预防指征为 GI 出血(n,%)(8,44%)、血清胆红素≥2.5mg/dl(6,33%)、先前的 SBP(2,11%)和 AF 蛋白≤1g/dl(2,11%)。P-SBP 中有 78%为社区获得性;22%为医院获得性。P-SBP 的院内死亡率为 16%(n=3)。仅有三分之一的 SBP 存活患者在出院后接受了长期门诊预防。
遵循 AASLD 指南可预防许多 SBP 病例。GI 出血是最常被忽视的 SBP 预防指征。有必要进行研究以确定不遵守指南的原因并制定干预措施以提高其使用率。